Matterhorn Capital Management’s Biogen BIIB Stock Holding History

Matterhorn Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-7,522	Closed	-$1.96M	–	59
2016 Q1	$1.96M	Sell	7,522 -4,905	-39%	-$1.3M	1.27%	38
2015 Q4	$3.81M	Buy	+12,427	New	+$3.57M	1.74%	30
2015 Q1	–	Sell	-10,601	Closed	-$3.6M	–	52
2014 Q4	$3.6M	Sell	10,601 -255	-2%	-$82.5K	1.69%	30
2014 Q3	$3.59M	Sell	10,856 -150	-1%	-$49.5K	1.61%	29
2014 Q2	$3.47M	Sell	11,006 -2,493	-18%	-$750K	1.54%	30
2014 Q1	$3.97M	Sell	13,499 -448	-3%	-$142K	1.83%	22
2013 Q4	$3.9M	Sell	13,947 -7	-0.1%	-$1.81K	1.8%	24
2013 Q3	$3.36M	Buy	+13,954	New	+$3.12M	1.68%	27

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Matterhorn Capital Management's BIIB Position: Q2 2016 in Review

Matterhorn Capital Management sold out of Biogen (BIIB) in Q2 2016, closing a stake of 7,522 shares — an estimated $1.96M sold.

Matterhorn Capital Management first reported a position in BIIB in Q3 2013 and held it in 8 quarters. The position peaked at $3.97M in Q1 2014. 965 funds tracked by Wall St. Rank hold BIIB as of Q2 2016.

Matterhorn Capital Management reported no remaining Biogen position as of Q2 2016 after selling out during the quarter.
Matterhorn Capital Management sold 7,522 Biogen shares in Q2 2016, an estimated $1.96M.
Matterhorn Capital Management first reported a position in Biogen in Q3 2013 and held it in 8 quarters.
Matterhorn Capital Management's Biogen position peaked at $3.97M in Q1 2014.
965 funds tracked by Wall St. Rank held Biogen as of Q2 2016.

Based on Matterhorn Capital Management's 13F filing for Q2 2016, filed 2 Aug 2016.